Melanoma Nanotherapy Prodrug Research Cites Cleanascite™ For Lipid Removal & Clarification

Melanoma Nanotherapy Prodrug Research Cites Cleanascite™ For Lipid Removal & Clarification

MONMOUTH JUNCTION, NJ – A research article in the journal NanoMedicine cites Biotech Support Group’s Cleanascite™ sample preparation reagent for two separate clarifications. The study evaluated the development of a phospholipid encapsulated c-Myc inhibitor prodrug and its potential use to prevent melanoma. The article states: 

“Background lipids can create artifactual errors when measuring the activity of lipase enzymes from serum or plasma. I am pleased to see that the selectivity profile of Cleanascite™ supports such important cancer related applications.”, states Dr. Swapan Roy, President & Founder of Biotech Support Group.

About Biotech Support Group LLC
Biotech Support Group LLC is a leading provider of proteomic, metabolomic and genomic sample preparation and enrichment products and services. It’s principal products include: AlbuVoid™ & AlbuSorb™ for albumin depletion, Cleanascite™ for lipid adsorption and clarification, HemogloBind™ & HemoVoid™ for hemoglobin removal, NuGel™ for functional & chemical proteomics, and ProCipitate™ for nucleic acid isolation. For more information, go to

Dr. Swapan Roy & Matthew Kuruc
Biotech Support Group LLC
1 Deer Park Drive, Suite M
Monmouth Junction NJ 08852
732-274-2866 Worldwide
800-935-0628 North America


Pan, Dipanjan, et al. “A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.” Nanomedicine 10.2 (2015): 241-251.

Suggested References

Dang, Chi V., et al. “Function of the c-Myc oncogenic transcription factor.” Experimental cell research 253.1 (1999): 63-77.

Zhuang, D., et al. “C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.” Oncogene 27.52 (2008): 6623-6634.

Wang, H., et al. “c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle.” Oncogene 27.13 (2008): 1905-1915.